1. Home
  2. |Insights
  3. |WEBINAR: Independent Research & Development Costs: Updates, Risks, and Compliance — C&M's First 100 Days Series

WEBINAR: Independent Research & Development Costs: Updates, Risks, and Compliance — C&M's First 100 Days Series

Webinar | 04.19.17, 9:00 AM EDT - 10:30 AM EDT

Provisions in the FY 2017 NDAA addressing IR&D follow a succession of changes (and potential changes) in the government’s approach to IR&D. With a new administration in office in 2017, government contractors need to be aware of the state of play in IR&D and how it may affect their business. What changes can you expect? What challenges could you face? Join Stephen McBrady and Skye Mathieson from Crowell & Moring on Wednesday, April 19 at 1:00 PM Eastern to find out. Our attorneys will discuss key issues and trends in IR&D including two new rules and subsequent changes, key risks, and potential compliance steps that contractors should consider with respect to IR&D.

For more information, please visit these areas: Government Contracts

Insights

Webinar | 12.10.26

The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations

The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.